v3.24.2
Stock-Based Compensation - Options Outstanding (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Apr. 28, 2024
Apr. 30, 2023
Number of Options    
Outstanding, beginning balance (in shares) 4,223,335,000  
Granted (in shares) 1,605,234,000  
Exercised (in shares) (47,395,000)  
Cancelled or expired (in shares) (1,089,473,000)  
Outstanding, ending balance (in shares) 4,691,701,000 4,223,335,000
Exercisable (in shares) 2,495,483,000  
Weighted-average Exercise Price    
Outstanding, beginning balance (in dollars per share) $ 5,330  
Granted (in dollars per share) 11.70  
Exercised (in dollars per share) 3.55  
Cancelled or expired (in dollars per share) 8.58  
Outstanding, ending balance (in dollars per share) 6.76 $ 5,330
Exercisable (in dollars per share) $ 4.37  
Weighted-average Remaining Contractual Term (in years) 6 years 5 months 4 days 6 years 6 months 21 days
Exercisable, Weighted-average Remaining Contractual Term (in years) 4 years 6 months  
Aggregate Intrinsic Value (in thousands) $ 0 $ 16,628
Aggregate Intrinsic Value (in thousands), Exercised $ 92  
Previously Reported    
Number of Options    
Outstanding, beginning balance (in shares) 2,284,399,000  
Outstanding, ending balance (in shares)   2,284,399,000
Weighted-average Exercise Price    
Outstanding, beginning balance (in dollars per share) $ 9.84  
Outstanding, ending balance (in dollars per share)   $ 9.84
Weighted-average Remaining Contractual Term (in years)   6 years 6 months 21 days
Aggregate Intrinsic Value (in thousands)   $ 16,628
Retroactive application of reverse recapitalization    
Number of Options    
Outstanding, beginning balance (in shares) 1,938,936,000  
Outstanding, ending balance (in shares)   1,938,936,000
Weighted-average Exercise Price    
Outstanding, beginning balance (in dollars per share) $ (4.51)  
Outstanding, ending balance (in dollars per share)   $ (4.51)
Aggregate Intrinsic Value (in thousands)   $ 0